STRATA Skin Sciences to Present at the Lytham Partners Spring 2021 Investor Conference
March 16 2021 - 7:00AM
STRATA Skin Sciences, Inc. (“STRATA”) (NASDAQ: SSKN), a medical
technology company in Dermatology and Plastic Surgery dedicated to
developing, commercializing and marketing innovative products for
the treatment of dermatologic conditions, today announced that the
company will participate in the upcoming Lytham Partners Spring
2021 Investor Conference.
STRATA Skin’s management is scheduled to present
on Tuesday, March 30, 2021, at 3:30 p.m. Eastern Time. Interested
parties may access a live and archived webcast of the presentation
on the “Investors” section of the company’s website at
www.strataskinsciences.com. Management will also participate in
virtual one-on-one meetings throughout the event, which runs from
March 30 through April 1, 2021. To request a meeting, please
contact Lytham Partners at 1x1@lythampartners.com, or register at
www.lythampartners.com/spring2021reg.
About STRATA Skin Sciences,
Inc. STRATA Skin Sciences is a medical technology company
in Dermatology and Plastic Surgery dedicated to developing,
commercializing and marketing innovative products for the treatment
of dermatologic conditions. Its products include the XTRAC® excimer
laser and VTRAC® lamp systems utilized in the treatment of
psoriasis, vitiligo and various other skin conditions.
The Company’s proprietary XTRAC® excimer laser
delivers a highly targeted therapeutic beam of UVB light to treat
psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma,
diseases which impact over 31 million patients in the United States
alone. The technology is covered by multiple patents, including
exclusive rights for patents for the delivery of treatment to
vitiligo patients.
STRATA’s unique business model leverages
targeted Direct to Consumer (DTC) advertising to generate awareness
and utilizes its in-house call center and insurance advocacy teams
to increase volume for the Company’s partner dermatology
clinics.
The XTRAC business has used this proven DTC
model to grow its domestic dermatology partner network to over 832
clinics, with a worldwide installed base of over 2,300 devices. The
Company is able to offer 90% of DTC patients an introduction to
physicians prescribing a reimbursable solution, using XTRAC, within
a 10-mile radius of their house. The Company is a leader in
dermatology in-clinic business generation for its partners.
The Company has now introduced its Home by
XTRAC™ business, leveraging in-house resources; including DTC
advertising, in-house call center and its insurance reimbursement
team to provide an at-home, insurance-reimbursed treatment option
for patients with certain skin diseases that do not qualify for
in-office treatments.
Investor Contacts:
Leigh Salvo |
|
|
(415) 937-5404 |
|
|
ir@strataskin.com |
|
|
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Apr 2023 to Apr 2024